Vasculitis Drug TAVNEOS Linked to 20 Deaths in Japan; Not Approved or Imported on Special Project Basis, Says Taiwan FDA
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
The vasculitis treatment drug "TAVNEOS" has been associated with 20 deaths in Japan. Taiwan's Food and Drug Administration (TFDA) announced that the drug is not approved in Taiwan and there are no records of clinical trials or special imports, denying any risk within the country.